SCHEMBL30656145

SCHEMBL30656145

Cc1sc2ccc(OCc3ccccc3F)cc2c1C(=O)NC1CCNC1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
APOL1 O14791 2/20 0.42
PARP15 Q460N3 1/20 0.42
PARP10 Q53GL7 1/20 0.42
SCN3A Q9NY46 7/20 0.40
KCNH2 Q12809 5/20 0.40
HPGDS O60760 4/20 0.39
SCN1A P35498 1/20 0.37
SCN4A P35499 1/20 0.37
SCN7A Q01118 1/20 0.37
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN8A Q9UQD0 1/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656206 0.88 APOL1 (0.49) APOL1HPGDSMAOB
SCHEMBL30656170 0.86 HPGDS (0.40) APOL1HPGDSSCN9A
SCHEMBL29712951 0.83 SLC26A4 (0.51) APOL1PARP15PARP10
SCHEMBL30656136 0.82 HPGDS (0.40) APOL1HPGDS
SCHEMBL30656100 0.82 SCN3A (0.38) PARP15PARP10SCN3AKCNH2MAOB
SCHEMBL30656040 0.82 SCN3A (0.38) PARP15PARP10SCN3AKCNH2MAOB
SCHEMBL26661096 0.81 KCNH2 (0.38) PARP15PARP10SCN3AKCNH2SCN1A
SCHEMBL30656342 0.81 KCNH2 (0.38) PARP15PARP10SCN3AKCNH2SCN1A
SCHEMBL31351337 0.78 PARP10 (0.48) PARP15PARP10SCN3ASCN9AMAOB
SCHEMBL26661115 0.78 PARP10 (0.48) PARP15PARP10SCN3ASCN9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed